|
US3855397A
(en)
|
1973-04-12 |
1974-12-17 |
Allied Chem |
Method of producing sodium carbonate and bicarbonate spherules from brine
|
|
US3898328A
(en)
*
|
1973-12-03 |
1975-08-05 |
Syntex Inc |
Dry stable composition for the treatment of scours and dehydration
|
|
DE2360794C2
(de)
|
1973-12-06 |
1984-12-06 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur Herstellung von Peptiden
|
|
IL44774A
(en)
*
|
1974-05-06 |
1977-07-31 |
Baron E |
Pharmaceutical composition containing acetyl salicyclic acid
|
|
GB1518364A
(en)
*
|
1976-05-05 |
1978-07-19 |
Beecham Group Ltd |
Pharmaceutical composition
|
|
GB1524740A
(en)
*
|
1976-11-09 |
1978-09-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions for use in the suppression of gastric reflux
|
|
US4108846A
(en)
|
1977-02-01 |
1978-08-22 |
Hoffmann-La Roche Inc. |
Solid phase synthesis with base N alpha-protecting group cleavage
|
|
US4289750A
(en)
*
|
1978-10-16 |
1981-09-15 |
Kopp Klaus F |
Therapy of conditions which may be associated with altered renal function and dosage forms therefor
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
JPS5822474B2
(ja)
|
1980-06-10 |
1983-05-09 |
天野製薬株式会社 |
コレシストキニン・パンクレオザイミンｃ端ペプチドアミドスルフエ−トエステルの製造法
|
|
US4351762A
(en)
|
1981-03-10 |
1982-09-28 |
Bioresearch, Inc. |
Rapid, quantitative peptide synthesis using mixed anhydrides
|
|
US4427660A
(en)
*
|
1982-03-03 |
1984-01-24 |
Research Corporation |
Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
|
|
US4571336A
(en)
*
|
1983-08-25 |
1986-02-18 |
Endorphin, Inc. |
Immune stimulation
|
|
US4977244A
(en)
*
|
1985-06-27 |
1990-12-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Uromodulin and a process of purifying it
|
|
US4651762A
(en)
*
|
1985-07-01 |
1987-03-24 |
Bowden Industries, Inc. |
Agitation parts degreaser
|
|
US4855285A
(en)
*
|
1985-12-04 |
1989-08-08 |
The Ohio State University Research Foundation |
Antigenic modification of polypeptides
|
|
DK237187A
(da)
|
1986-05-12 |
1987-11-13 |
Wellcome Found |
Farmaceutisk anvendelse af t-pa
|
|
GB2194866A
(en)
|
1986-07-14 |
1988-03-16 |
British Broadcasting Corp |
Timing signals
|
|
US4753965A
(en)
*
|
1987-04-09 |
1988-06-28 |
Merrell Dow Pharmaceuticals, Inc. |
Method of treating multiple sclerosis with chalcone derivatives
|
|
US5002961A
(en)
*
|
1987-10-19 |
1991-03-26 |
Merrell Dow Pharmaceuticals |
Method for reducing injury with imidazol-2-thionecarboxamides
|
|
US4966848A
(en)
|
1988-02-08 |
1990-10-30 |
The General Hospital Corporation |
Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
ATE136551T1
(de)
|
1988-05-10 |
1996-04-15 |
Alpha 1 Biomedicals Inc |
Festphase-verfahren zur gewinnung von thymosin- alpha-1
|
|
US5055447A
(en)
|
1988-07-28 |
1991-10-08 |
Genentech, Inc. |
Method and compositions for the treatment and prevention of septic shock
|
|
US5175254A
(en)
|
1988-09-24 |
1992-12-29 |
Societe D'expansion Scientifque Expansia |
Solid phase peptide synthesis using a polyacrylic support in aqueous solution
|
|
US5308834A
(en)
|
1989-02-14 |
1994-05-03 |
Incyte Pharmaceuticals, Inc. |
Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
|
|
US6309822B1
(en)
|
1989-06-07 |
2001-10-30 |
Affymetrix, Inc. |
Method for comparing copy number of nucleic acid sequences
|
|
US5102393A
(en)
*
|
1989-07-17 |
1992-04-07 |
Survival Technology, Inc. |
Autoinjector converted from intramuscular to subcutaneous mode of injection
|
|
US5223421A
(en)
|
1989-10-25 |
1993-06-29 |
The General Hospital Corporation |
Identification of methionine Nα-acetyltransferase
|
|
US5070187A
(en)
|
1989-11-03 |
1991-12-03 |
Trustees Of Boston University |
Pharmacologically effective antagonists of arginine-vasopressin
|
|
US6051596A
(en)
*
|
1990-08-10 |
2000-04-18 |
Anormed, Inc. |
Immunosuppressive compositions
|
|
CA2050425A1
(en)
|
1990-09-03 |
1992-03-04 |
Yoshiaki Uda |
Pharmaceutical composition and its mucous use
|
|
US5958413A
(en)
*
|
1990-11-01 |
1999-09-28 |
Celltech Limited |
Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
|
|
US5200507A
(en)
|
1991-04-12 |
1993-04-06 |
Mallinckrodt Specialty Chemicals Company |
Method of separating a peptide from a resin
|
|
AU2140592A
(en)
|
1991-05-17 |
1992-12-30 |
Chiron Corporation |
Inhibitor of nf-kappa b transcriptional activator and uses thereof
|
|
US5223397A
(en)
*
|
1991-06-05 |
1993-06-29 |
Sangstat Medical Corporation |
Soluble hla cross-match
|
|
DE4138621A1
(de)
*
|
1991-11-25 |
1993-06-17 |
Boehringer Ingelheim Int |
Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
|
|
DK0633929T3
(da)
*
|
1992-04-01 |
2004-06-28 |
Univ Rockefeller |
Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener
|
|
ATE152734T1
(de)
*
|
1992-05-30 |
1997-05-15 |
Sikiric Predrag |
Bpc-peptide, deren herstellung und verwendung
|
|
US5436270A
(en)
|
1993-04-07 |
1995-07-25 |
National Science Council |
Method for protecting against endotoxin-induced shock
|
|
FR2706772A1
(en)
|
1993-06-22 |
1994-12-30 |
Vacsyn Sa |
Prevention and treatment of septic syndrome with an immunosuppressant, in particular cyclosporin.
|
|
US5380668A
(en)
*
|
1993-07-06 |
1995-01-10 |
University Of Utah Research Foundation |
Compounds having the antigenicity of hCG
|
|
PT1118325E
(pt)
*
|
1993-07-29 |
2006-05-31 |
Us Health |
Utilizacao de paclitaxel e seus derivados na preparacao de um medicamento para o tratamento de restenose
|
|
US5837478A
(en)
|
1993-12-23 |
1998-11-17 |
Icos Corporation |
Method of identifying modulators of binding between and VCAM-1
|
|
NZ278607A
(en)
*
|
1994-02-07 |
1999-05-28 |
Knoll Ag |
Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
US5677275A
(en)
*
|
1994-08-05 |
1997-10-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of cancer with human chorionic gonadotropin
|
|
GB2293100A
(en)
*
|
1994-09-15 |
1996-03-20 |
Medeva Europ Ltd |
Pharmaceutical compositions with deuterium oxide
|
|
US5851997A
(en)
*
|
1994-10-04 |
1998-12-22 |
Harris; Pamela Jo |
Use of human chorionic gonadotropin as an immune-potentiating antiviral agent
|
|
US5700781A
(en)
|
1994-10-04 |
1997-12-23 |
Harris; Pamela Jo |
Method for treating Kaposi's sarcoma and HIV infections
|
|
SE520730C2
(sv)
*
|
1995-01-20 |
2003-08-19 |
Eskil Elmer |
Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel
|
|
WO1996032412A1
(fr)
*
|
1995-04-13 |
1996-10-17 |
Chugai Seiyaku Kabushiki Kaisha |
PEPTIDE SUPPRIMANT LA PHOSPHORYLATION IxB$g(a)
|
|
US5688489A
(en)
|
1995-09-15 |
1997-11-18 |
Resolution Pharmaceuticals, Inc. |
Non-receptor mediated imaging agents
|
|
US5942494A
(en)
*
|
1995-10-06 |
1999-08-24 |
The Trustees Of Columbia University In The City Of New York |
Stimulation of gene expression and synthesis of heat shock protein 72/73 (HSP 70)
|
|
JP2860637B2
(ja)
*
|
1995-12-11 |
1999-02-24 |
末綱 陽子 |
新規なペプチドおよび活性化酸素阻害剤
|
|
JP2835504B2
(ja)
*
|
1995-12-11 |
1998-12-14 |
末綱 陽子 |
新規なペプチドおよび活性化酸素阻害剤
|
|
JPH09176187A
(ja)
*
|
1995-12-27 |
1997-07-08 |
Kagaku Gijutsucho Hoshasen Igaku Sogo Kenkyusho |
活性酸素消去能を有するヒスチジン含有ペプチド
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
US6361992B1
(en)
*
|
1996-05-08 |
2002-03-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thyroid stimulating hormone superagonists
|
|
US6207145B1
(en)
|
1997-05-09 |
2001-03-27 |
Pharma Pacific Pty Ltd. |
Therapeutic applications of high dose interferon
|
|
US6319504B1
(en)
*
|
1996-06-24 |
2001-11-20 |
University Of Maryland Biotechnology Institute |
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
|
|
US5997871A
(en)
*
|
1996-06-24 |
1999-12-07 |
University Of Maryland Biotechnology Insitute |
Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
|
|
US5968513A
(en)
*
|
1996-06-24 |
1999-10-19 |
University Of Maryland Biotechnology Institute |
Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
|
|
CA2180786C
(en)
|
1996-07-02 |
2008-05-27 |
David Lightfoot |
Plants containing the gdha gene and methods of use thereof
|
|
US6150500A
(en)
*
|
1996-07-12 |
2000-11-21 |
Salerno; John C. |
Activators of endothelial nitric oxide synthase
|
|
GB9617021D0
(en)
|
1996-08-13 |
1996-09-25 |
Salpep Biotechnology Inc |
Novel peptides for treatment of inflammation and shock
|
|
US6361922B1
(en)
*
|
1996-10-16 |
2002-03-26 |
Eastman Kodak Company |
Thicker optical recording layers comprising a tetra dye having a metallized azo dianionic dye with cationic dye counterions
|
|
GB9624927D0
(en)
|
1996-11-29 |
1997-01-15 |
Oxford Glycosciences Uk Ltd |
Gels and their use
|
|
US5966712A
(en)
|
1996-12-12 |
1999-10-12 |
Incyte Pharmaceuticals, Inc. |
Database and system for storing, comparing and displaying genomic information
|
|
WO1998034631A1
(en)
|
1997-02-07 |
1998-08-13 |
Thomas Jefferson University |
Peptide mimetics of the cytokine receptor gamma chain
|
|
NZ337364A
(en)
|
1997-02-15 |
2001-06-29 |
Millennium Pharm Inc |
Treatment of infarcts, ischemia and reperfusion through inhibition of NFkappaB
|
|
US6416959B1
(en)
|
1997-02-27 |
2002-07-09 |
Kenneth Giuliano |
System for cell-based screening
|
|
ATE354089T1
(de)
|
1997-04-07 |
2007-03-15 |
Fisher Bioimage Aps |
Ein verfahren zum screenen von substanzen hinsichtlich ihres effekts auf camp spiegel basierend auf intrazellulärer translokation von pka
|
|
US5801193A
(en)
*
|
1997-04-15 |
1998-09-01 |
Immune Modulation, Inc. |
Compositions and methods for immunosuppressing
|
|
US6583109B1
(en)
*
|
1997-06-24 |
2003-06-24 |
Robert C. Gallo |
Therapeutic polypeptides from β-hCG and derivatives
|
|
DE19735587B4
(de)
*
|
1997-08-16 |
2012-03-22 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens
|
|
HUP0001237A3
(en)
*
|
1997-10-20 |
2002-01-28 |
Lilly Co Eli |
Methods for treating vascular disorders
|
|
US6831057B2
(en)
*
|
1997-10-28 |
2004-12-14 |
The University Of North Carolina At Chapel Hill |
Use of NF-κB inhibition in combination therapy for cancer
|
|
ES2276481T3
(es)
|
1997-12-12 |
2007-06-16 |
The University Of Western Ontario |
Peptido apoep1.b novedoso, composiciones y sus usos.
|
|
US6075150A
(en)
*
|
1998-01-26 |
2000-06-13 |
Cv Therapeutics, Inc. |
α-ketoamide inhibitors of 20S proteasome
|
|
US6022696A
(en)
|
1998-04-02 |
2000-02-08 |
Washington State University Research Foundation |
Methods of identifying agonists or antagonists of angiotensin IV
|
|
US7175679B2
(en)
*
|
2001-03-29 |
2007-02-13 |
Biotempt B.V. |
Oligopeptide treatment of NF-κB mediated inflammation
|
|
US6844315B2
(en)
*
|
1998-05-20 |
2005-01-18 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US20090042807A1
(en)
|
1998-05-20 |
2009-02-12 |
Nisar Ahmed Khan |
Oligopeptide treatment of ischemia reperfusion injury
|
|
US20050227925A1
(en)
*
|
2004-04-08 |
2005-10-13 |
Robbert Benner |
Compositions capable of reducing elevated blood urea concentration
|
|
EP1138692A1
(en)
*
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
|
US20040202645A1
(en)
|
2003-04-08 |
2004-10-14 |
Khan Nisar Ahmed |
Administration of gene-regulatory peptides
|
|
US8680059B2
(en)
|
1998-05-20 |
2014-03-25 |
Biotempt B.V. |
Oligopeptide acetate and formulations thereof
|
|
US6921751B1
(en)
|
1998-05-20 |
2005-07-26 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US20030220258A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of ischemic events
|
|
WO1999061617A1
(en)
|
1998-05-29 |
1999-12-02 |
Human Genome Sciences, Inc. |
Interleukins-21 and 22
|
|
RU2139085C1
(ru)
*
|
1998-06-23 |
1999-10-10 |
Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" |
Средство, стимулирующее репаративные процессы, и способ его применения
|
|
WO2000031124A2
(en)
|
1998-11-20 |
2000-06-02 |
Mount Sinai Hospital |
Peptides that modulate the interaction of b class ephrins and pdz domains
|
|
US6507788B1
(en)
|
1999-02-25 |
2003-01-14 |
Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) |
Rational selection of putative peptides from identified nucleotide, or peptide sequences, of unknown function
|
|
EP1560590B1
(en)
*
|
1999-03-09 |
2008-10-22 |
Fornix Biosciences N.V. |
Synthetic complementary peptides and ophthalmologic uses thereof
|
|
US20030148955A1
(en)
|
1999-04-19 |
2003-08-07 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
|
US6379970B1
(en)
|
1999-04-30 |
2002-04-30 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Analysis of differential protein expression
|
|
RU2157233C1
(ru)
*
|
1999-05-11 |
2000-10-10 |
Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" |
Тетрапептид, обладающий геропротекторной активностью, фармакологическое средство на его основе и способ его применения
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
JP2003506411A
(ja)
|
1999-08-09 |
2003-02-18 |
トリペップ アクチ ボラゲット |
タンパク質重合阻害剤および使用方法
|
|
GB0005702D0
(en)
|
2000-03-09 |
2000-05-03 |
Alpharma As |
Method
|
|
US6864355B1
(en)
|
2000-05-02 |
2005-03-08 |
Yale University |
Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
|
|
IL149125A0
(en)
|
1999-10-15 |
2002-11-10 |
Histatek Llc |
N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent
|
|
RU2155063C1
(ru)
|
1999-10-20 |
2000-08-27 |
Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" |
Тетрапептид, стимулирующий функциональную активность нейронов, фармакологическое средство на его основе и способ его применения
|
|
DE19953339A1
(de)
|
1999-11-05 |
2001-05-17 |
Goldham Pharma Gmbh |
Secretinfragmente
|
|
JP2003518477A
(ja)
|
1999-11-18 |
2003-06-10 |
セレメディックス，インク． |
反応性酸素種およびフリーラジカルの効力を中和するための組成物および方法
|
|
CA2397485A1
(en)
*
|
2000-01-14 |
2001-07-19 |
Science & Technology Corporation @ Unm |
Peptide inhibitors of lfa-1/icam-1 interaction
|
|
AU2001232799A1
(en)
*
|
2000-02-11 |
2001-08-20 |
Eli Lilly And Company |
Protein c derivatives
|
|
AU2001245537A1
(en)
|
2000-03-10 |
2001-09-24 |
Monsanto Company |
Anti-hypertensive peptides
|
|
US7358330B2
(en)
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
|
US7576174B2
(en)
|
2000-03-29 |
2009-08-18 |
Biotempt B.V. |
Compositions capable of reducing elevated blood urea concentration
|
|
EP1300418A1
(en)
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
|
US20050037430A1
(en)
*
|
2000-03-29 |
2005-02-17 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
|
US6783757B2
(en)
*
|
2000-06-01 |
2004-08-31 |
Kirkman Group, Inc. |
Composition and method for increasing exorphin catabolism to treat autism
|
|
US6586403B1
(en)
|
2000-07-20 |
2003-07-01 |
Salpep Biotechnology, Inc. |
Treating allergic reactions and inflammatory responses with tri-and dipeptides
|
|
US6539102B1
(en)
|
2000-09-01 |
2003-03-25 |
Large Scale Proteomics |
Reference database
|
|
EP1217540A1
(en)
|
2000-11-29 |
2002-06-26 |
Lafayette Software Inc. |
Methods of organizing data and processing queries in a database system, and database system and software product for implementing such method
|
|
US20020155106A1
(en)
|
2000-12-01 |
2002-10-24 |
Hammond David J. |
Method of identifying a ligand for a target molecule
|
|
US20060073550A1
(en)
*
|
2001-01-16 |
2006-04-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2002069892A2
(en)
*
|
2001-02-28 |
2002-09-12 |
Temple University Of The Commonwealth System Of Higher Education |
METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH α, β UNSATURATED ARYL SULFONES
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
US6894028B2
(en)
|
2001-04-06 |
2005-05-17 |
Zengen, Inc. |
Use of KPV tripeptide for dermatological disorders
|
|
JP2004536062A
(ja)
|
2001-05-17 |
2004-12-02 |
セレメディックス，インク． |
反応性酸素種およびフリーラジカルの効力を中和するためのペプチド化合物
|
|
CA2448668A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Trillium Therapeutics Inc. |
Modulation of cd200 receptors
|
|
US20040072246A1
(en)
|
2001-09-11 |
2004-04-15 |
Roland Martin |
System and method for identifying t cell and other epitopes and the like
|
|
US20030220259A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of neurological disorders
|
|
US20040013661A1
(en)
*
|
2001-12-21 |
2004-01-22 |
Gert Wensvoort |
Stratification
|
|
US20030220257A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of trauma
|
|
US20080242618A1
(en)
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Stratification
|
|
US20030220261A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Khan Nisar Ahmed |
Treatment of iatrogenic disease
|
|
US20080242837A1
(en)
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
|
US7560433B2
(en)
*
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
|
US7501391B2
(en)
*
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
|
US20030224995A1
(en)
*
|
2001-12-21 |
2003-12-04 |
Khan Nisar Ahmed |
Treatment of burns
|
|
US20030220260A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Khan Nisar Ahmed |
Peptide compositions
|
|
US20080194489A1
(en)
|
2001-12-21 |
2008-08-14 |
Khan Nisar A |
Treatment of iatrogenic disease
|
|
US7786084B2
(en)
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
|
US7135286B2
(en)
*
|
2002-03-26 |
2006-11-14 |
Perlegen Sciences, Inc. |
Pharmaceutical and diagnostic business systems and methods
|
|
AU2003250810A1
(en)
|
2002-08-15 |
2004-03-03 |
Leuketoch A/S |
Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
|
|
US7517529B2
(en)
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
|
EP1466612A1
(en)
|
2003-04-08 |
2004-10-13 |
Biotempt B.V. |
Treatment of inflammation and sepsis with hCG derived peptides
|
|
US7513755B2
(en)
*
|
2003-07-03 |
2009-04-07 |
Vaporless Manufacturing, Inc. |
Submerged motor and pump assembly
|
|
CA2534461A1
(en)
|
2003-08-05 |
2005-02-10 |
Green Peptide Co., Ltd |
An agent for preventing and/or treating hematologic malignancies
|
|
IL157772A
(en)
*
|
2003-09-04 |
2016-06-30 |
Bmr Solutions Ltd |
Compounds containing oligopeptide derived from turtle larvae and their use to encourage mammalian hemophysis
|
|
ES2365852T3
(es)
*
|
2003-11-07 |
2011-10-11 |
Novartis Ag |
Utilización de fragmentos del factor de crecimiento de fibroblastos.
|
|
US7638485B2
(en)
|
2003-12-02 |
2009-12-29 |
Cleveland Biolabs, Inc. |
Modulating apoptosis
|
|
US20090227505A1
(en)
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
|
US7420632B2
(en)
*
|
2004-03-31 |
2008-09-02 |
Toyo Ink Mfg. Co., Ltd. |
Color filter and liquid crystal display device provided with the same
|
|
JP5285278B2
(ja)
|
2004-12-22 |
2013-09-11 |
クリーブランド クリニック ファウンデイション |
フラゲリン関連ポリペプチドおよびその使用
|
|
SG163567A1
(en)
|
2005-07-05 |
2010-08-30 |
Biotempt Bv |
Treatment of tumors
|
|
EP1864692A1
(en)
|
2006-06-07 |
2007-12-12 |
Biotempt B.V. |
Use of peptides for the control of radiation injury
|
|
CA2677948C
(en)
|
2007-02-12 |
2014-12-09 |
Biotempt B.V. |
Treatment of trauma-hemorrhage with short oligopeptides
|
|
EP2109054A1
(en)
*
|
2008-04-09 |
2009-10-14 |
Biotempt B.V. |
Methods for identifying biologically active peptides and predicting their function
|